Systemic treatment for oesophageal cancer

This publication has 71 references indexed in Scilit:

• Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus
  Annals of Oncology, 2003
• Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
  New England Journal of Medicine, 2002
• Cancer burden in the year 2000. The global picture
  Published by Elsevier ,2001
• Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the Esophagus
  The American Journal of Pathology, 1999
• Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
  New England Journal of Medicine, 1999
• Body Mass Index and Risk of Adenocarcinomas of the Esophagus and Gastric Cardia
  JNCI Journal of the National Cancer Institute, 1998
• Chemotherapy and Combined-Modality Therapy for Esophageal Cancer
  Chest, 1995
• A 15-Year Review of Esophagectomy for Carcinoma of the Esophagus and Cardia
  Archives of Surgery, 1995
• Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer
  World Journal of Surgery, 1992
• Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus
  The Annals of Thoracic Surgery, 1988